MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/03/6401-85-93$20.00
Mol Pharmacol 64:85-93, 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ianaro, A.
Right arrow Articles by Santoro, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ianaro, A.
Right arrow Articles by Santoro, M. G.

Anti-Inflammatory Activity of 15-Deoxy-{Delta}12,14-PGJ2 and 2-Cyclopenten-1-one: Role of the Heat Shock Response

Angela Ianaro, Armando Ialenti, Pasquale Maffia, Paola Di Meglio, Massimo Di Rosa, and M. Gabriella Santoro

Department of Experimental Pharmacology, University of Naples Federico II, Naples, Italy (A.I., A.I., P.D.M., M.D.R.); Department of Pharmaceutical Sciences, University of Salerno, Fisciano, Italy (P.M.); and Department of Biology, University of Rome Tor Vergata, Rome, Italy (A.Ian., M.G.S.)

The transcription factor heat shock factor 1 (HSF1) plays a key role in the expression of several genes, such as heat shock protein (hsp) genes, which are cytoprotective against several pathological conditions, including inflammation. Cyclopentenone prostaglandins (cyPG) are able to activate HSF1 and induce the synthesis of the 70-kDa hsp (hsp70) in mammalian cells. These molecules are characterized by the presence of a reactive {alpha},{beta}-unsatured carbonyl group in the cyclopentane ring (cyclopentenone) which is the key structure for triggering HSF1 activation. In the present study, we investigated, in carrageenin hind-paw edema, an acute model of inflammation, the effect of double-stranded oligodeoxynucleotides with consensus HSF1 sequence as transcription factor decoys to inhibit HSF1 binding to native DNA sites. We show that HSF1 activation and hsp72 expression occurs in inflamed tissue and that this effect is associated with the remission of the inflammatory reaction. Moreover, we studied the effect of prostaglandin 15-deoxy-{Delta}12,14-prostaglandin (PG) J2, of its precursor, PGD2 and, for the first time in vivo, the effect of the cyclopentenone ring structure itself, 2-cyclopenten-1-one. Our results demonstrated that all agents used had anti-inflammatory properties and that this effect was associated with HSF1-induced hsp72 expression in vivo, suggesting that the use of cyclopentenone derivatives may represent a novel therapeutic approach to the treatment of inflammatory diseases.


Received December 26, 2002; accepted April 4, 2003

Address correspondence to: Angela Ianaro, Department of Experimental Pharmacology, University of Naples Federico II, Via D. Montesano 4, 80131, Naples, Italy. E-mail: ianaro{at}unina.it




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
C. Fionda, F. Nappi, M. Piccoli, L. Frati, A. Santoni, and M. Cippitelli
Inhibition of Trail Gene Expression by Cyclopentenonic Prostaglandin 15-Deoxy-{Delta}12,14-Prostaglandin J2 in T Lymphocytes
Mol. Pharmacol., November 1, 2007; 72(5): 1246 - 1257.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. Stamatakis, F. J. Sanchez-Gomez, and D. Perez-Sala
Identification of Novel Protein Targets for Modification by 15-Deoxy-{Delta}12,14-Prostaglandin J2 in Mesangial Cells Reveals Multiple Interactions with the Cytoskeleton
J. Am. Soc. Nephrol., January 1, 2006; 17(1): 89 - 98.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Nickerson, G. F. Elphick, J. Campisi, B. N. Greenwood, and M. Fleshner
Physical activity alters the brain Hsp72 and IL-1{beta} responses to peripheral E. coli challenge
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2005; 289(6): R1665 - R1674.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. S. Musiek, L. Gao, G. L. Milne, W. Han, M. B. Everhart, D. Wang, M. G. Backlund, R. N. DuBois, G. Zanoni, G. Vidari, et al.
Cyclopentenone Isoprostanes Inhibit the Inflammatory Response in Macrophages
J. Biol. Chem., October 21, 2005; 280(42): 35562 - 35570.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. Esposito, A. Iacono, G. M. Raso, M. Pacilio, A. Coppola, R. Di Carlo, and R. Meli
Raloxifene, a Selective Estrogen Receptor Modulator, Reduces Carrageenan-Induced Acute Inflammation in Normal and Ovariectomized Rats
Endocrinology, August 1, 2005; 146(8): 3301 - 3308.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Ialenti, G. Grassia, P. Di Meglio, P. Maffia, M. Di Rosa, and A. Ianaro
Mechanism of the Anti-Inflammatory Effect of Thiazolidinediones: Relationship with the Glucocorticoid Pathway
Mol. Pharmacol., May 1, 2005; 67(5): 1620 - 1628.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
F. J. Sanchez-Gomez, E. Cernuda-Morollon, K. Stamatakis, and D. Perez-Sala
Protein Thiol Modification by 15-deoxy-{Delta}12,14-Prostaglandin J2 Addition in Mesangial Cells: Role in the Inhibition of Pro-inflammatory Genes
Mol. Pharmacol., November 1, 2004; 66(5): 1349 - 1358.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics